The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
The Age-related Eye Disease Study 2 (AREDS2)
Open accessAbstract
Purpose The Age-Related Eye Disease Study (AREDS) demonstrated beneficial effects of oral supplementation with antioxidant vitamins and minerals on the development of advanced age-related macular degeneration (AMD) in persons with at least intermediate AMD (bilateral large drusen with or without pigment changes). Observational data suggest that other oral nutrient supplements might further reduce the risk of progression to advanced AMD. The primary purpose of Age-Related Eye Disease Study 2 (AREDS2) is to evaluate the efficacy and safety of lutein+zeaxanthin (L+Z) and/or omega-3 long-chain polyunsaturated fatty acid (LCPUFA) supplementation in reducing the risk of developing advanced AMD. The study will also assess the reduction in zinc and the omission of beta-carotene from original AREDS formulation. Design Multicenter phase 3 randomized controlled clinical trial Participants Persons age 50 to 85 with bilateral intermediate AMD or advanced AMD in one eye Methods All participants were randomly assigned to: 1) placebo (n=1012); 2) L+Z (10 mg/2 mg, n=1044); 3) ω-3 LCPUFAs (eicosapentaenoic acid (EPA) + docosahexaenoic acid (DHA) [650gmg/350 mg] n=1069); or 4) the combination of L+Z and ω -3 LCPUFAs (n=1078). All participants were offered a secondary randomization to 1 of 4 variations of the original AREDS formulation keeping vitamins C (500 mg), E (400 IU), and copper (2 mg) unchanged while varying zinc and beta-carotene as follows: zinc remains at the original level (80mg), lower only zinc to 25mg, omit beta-carotene only, or lower zinc to 25 mg and omit beta-carotene. Main Outcome Measures Progression to advanced AMD determined by centralized grading of annual fundus photographs. Results 4,203 participants were enrolled at 82 clinical centers located in the U.S. Population characteristics at baseline were as follows: mean age 74 years, 57% female, 97% white, 7% current smokers, 19% with prior cardiovascular disease and 44% and 50% taking statin-class cholesterol lowering drugs and aspirin, respectively. Ocular characteristics include 59% with bilateral large drusen, 32% with advanced AMD in one eye and mean visual acuity of 20/32 in eyes without advanced AMD. Conclusion This report presents the AREDS2 study design and the participants’ baseline demographic and ocular characteristics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trumbo (2001) · doi:10.1016/s0002-8223(01)00078-5 · Cited by 4,852
(2001) · National Academies Press eBooks · doi:10.17226/10026 · Cited by 3,023
Prevalence of Age-Related Macular Degeneration in the United States
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.564 · Cited by 2,736
Causes and Prevalence of Visual Impairment Among Adults in the UnitedStates
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.4.477 · Cited by 2,616
Regression analysis of multivariate incomplete failure time data by modeling marginal distributions
Wei, L. J., Lin, D. Y., & Weissfeld, L. (1989) · Journal of the American Statistical Association · doi:10.1080/01621459.1989.10478873 · Cited by 1,868
Omenn, G. S., Goodman, G. E., Thornquist, M. D., Balmes, J., Cullen, M. R., Glass, A., Keogh, J. P., Meyskens, F. L., Valanis, B., Williams, J. H., et al. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.21.1550 · Cited by 1,255
Chemistry and metabolism of lipids in the vertebrate retina
Fliesler, A. J., & Anderson, R. E. (1983) · Progress in Lipid Research · doi:10.1016/0163-7827(83)90004-8 · Cited by 1,052
Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration
Seddon, J. M. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03520180037032 · Cited by 993
The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina
SanGiovanni, J. P., & Chew, E. Y. (2005) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2004.06.002 · Cited by 874
Self-citation
Cited by
Algorithmic fairness in artificial intelligence for medicine and healthcare
Chen, R. J., Wang, J. J., Williamson, D. F. K., Chen, T. Y., Lipkova, J., Lu, M. Y., Sahai, S., & Mahmood, F. (2023) · Nature Biomedical Engineering · doi:10.1038/s41551-023-01056-8 · Cited by 750
Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Abdelhamid, A. S., Brown, T. J., Brainard, J. S., Biswas, P., Thorpe, G. C., Moore, H. J., Deane, K. H., AlAbdulghafoor, F. K., Summerbell, C. D., Worthington, H. V., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003177.pub3 · Cited by 630
Chew, E. Y., Clemons, T. E., SanGiovanni, J. P., Danis, R. P., Ferris, F. L., Elman, M. J., Antoszyk, A. N., Ruby, A. J., Orth, D., Bressler, S. B., et al. (2014) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2013.7376 · Cited by 415
Self-citationOmega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Abdelhamid, A. S., Brown, T. J., Brainard, J. S., Biswas, P., Thorpe, G. C., Moore, H. J., Deane, K. H., AlAbdulghafoor, F. K., Summerbell, C. D., Worthington, H. V., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003177.pub4 · Cited by 405
Farsiu, S., Chiu, S. J., O'Connell, R. V., Folgar, F. A., Yuan, E., Izatt, J. A., & Toth, C. A. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2013.07.013 · Cited by 368
Laíns, I., Wang, J. C., Cui, Y., Katz, R., Vingopoulos, F., Staurenghi, G., Vavvas, D. G., Miller, J. W., & Miller, J. B. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100951 · Cited by 324
Evans, J. R., & Lawrenson, J. G. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000254.pub4 · Cited by 335
Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Abdelhamid, A. S., Brown, T. J., Brainard, J. S., Biswas, P., Thorpe, G. C., Moore, H. J., Deane, K. H., Summerbell, C. D., Worthington, H. V., Song, F., et al. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003177.pub5 · Cited by 295
Fuchs endothelial corneal dystrophy: The vicious cycle of Fuchs pathogenesis
Ong Tone, S., Kocaba, V., Böhm, M., Wylegala, A., White, T. L., & Jurkunas, U. V. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100863 · Cited by 284
A new perspective on lipid research in age-related macular degeneration
van Leeuwen, E. M., Emri, E., Merle, B. M. J., Colijn, J. M., Kersten, E., Cougnard-Gregoire, A., Dammeier, S., Meester-Smoor, M., Pool, F. M., de Jong, E. K., et al. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.04.006 · Cited by 247
Chew, E. Y., Clemons, T. E., Agrón, E., Launer, L. J., Grodstein, F., & Bernstein, P. S. (2015) · JAMA · doi:10.1001/jama.2015.9677 · Cited by 191
Self-citationLee, K. S., Lin, S., Copland, D. A., Dick, A. D., & Liu, J. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02088-0 · Cited by 150
Bonds, D. E., Harrington, M., Worrall, B. B., Bertoni, A. G., Eaton, C. B., Hsia, J., Robinson, J., Clemons, T. E., Fine, L. J., & Chew, E. Y. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.328 · Cited by 118
Self-citationRetinal specialist versus artificial intelligence detection of retinal fluid from OCT
Keenan, T. D. L., Clemons, T. E., Domalpally, A., Elman, M. J., Havilio, M., Agrón, E., Benyamini, G., & Chew, E. Y. (2021) · Ophthalmology · doi:10.1016/j.ophtha.2020.06.038 · Cited by 93
Self-citationMerle, B. M. J., Delyfer, M.-N., Korobelnik, J.-F., Rougier, M.-B., Malet, F., Féart, C., Le Goff, M., Peuchant, E., Letenneur, L., Dartigues, J.-F., et al. (2013) · The Journal of Nutrition · doi:10.3945/jn.112.171033 · Cited by 78
Maurya, M., Bora, K., Blomfield, A. K., Pavlovich, M. C., Huang, S., Liu, C.-H., & Chen, J. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.369098 · Cited by 63
“AREDS2 study further improved the formula with lutein (10 mg) and zeaxanthin (2 mg), both carotenoids, replacing beta-carotene, to eliminate the concern of beta-carotene in increased lung cancer risk (Chew et al., 2012; AREDS2, 2013).”
Antioxidant Nutraceutical Strategies in the Prevention of Oxidative Stress Related Eye Diseases
Rodella, U., Honisch, C., Gatto, C., Ruzza, P., & D’Amato Tóthová, J. (2023) · Nutrients · doi:10.3390/nu15102283 · Cited by 59
van Asten, F., Chiu, C.-Y., Agrón, E., Clemons, T. E., Ratnapriya, R., Swaroop, A., Klein, M. L., Fan, R., & Chew, E. Y. (2019) · Ophthalmology · doi:10.1016/j.ophtha.2019.06.004 · Cited by 27
Self-citationProkopiou, E., Kolovos, P., Kalogerou, M., Neokleous, A., Papagregoriou, G., Deltas, C., Malas, S., & Georgiou, T. (2017) · BMJ Open Ophthalmology · doi:10.1136/bmjophth-2016-000056 · Cited by 16
Metadata
- Authors
- Chew, E. Y., Clemons, T., SanGiovanni, J. P., Danis, R., Domalpally, A., McBee, W., Sperduto, R., & Ferris, F. L.
- Venue
- Ophthalmology
- Publisher
- Elsevier BV
- Published
- 2012-11
- Volume
- 119
- Issue
- 11
- Pages
- 2282-2289
- ISSN
- 0161-6420 (ISSN-L)
- OpenAlex
- W2154864949
- Cited by
- 415
- References
- 43
- FWCI
- 19.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.